NRXN3 and Alzheimer disease: In AD samples, neurons showed downregulation of GABA receptor (GABRA2, GABRB1), glutamate receptor (GRIA2, GRID2), and neurexin (NRXN1, NRXN3) genes, consistent with the loss of synapses seen in AD.